Abstract
SR vesicles [9] . These findings suggested that the gating by 21 days of rapid right-ventricular pacing at a rate of 250 21 function of the SR Ca release channel is altered in heart bpm using an externally programmable miniature pacefailure.
maker (Medtronic, Minneapolis, USA) as described previIn skeletal muscle, it has been shown that an associate ously [9] . Each dog was sedated with morphine sulfate (15 protein, FKBP12, is both copurified with RyR during mg, s.c.) and cromazine maleate (10 mg, s.c.), then, sucrose-density-gradient centrifugation and colocalized anesthetized with isoflurane (2%, 1.5 l / min) and a mixture with RyR to the terminal cisternae of the SR, and also that of nitrous oxide and oxygen (50:50), intubated with a FKBP12 antibody can immunoprecipitate RyR [10] . The cuffed endotracheal tube and ventilated at a tidal volume physiological function of FKBP12 is modulation of RyR-1, of 22 ml / kg and a respiratory rate of 15 breaths per 21 the skeletal muscle isoform of the Ca -release channel, a minute. A bipolar pacing lead was fixed to the endocardial role it may play by enhancing cooperation among the four RV surface and its distal ends were tunneled to a subcutasubunits of RyR-1 [10] [11] [12] . Recently, a novel FKBP with neous pocket constructed on the animal's back, where they a different electrophoretic mobility (FKBP12.6) was found were connected to a pacemaker (Medtronic). modified to to be specifically associated with RyR-2, the cardiac pace at 250 bpm. The thoracotomy was then closed in muscle isoform [13, 14] . The stoichiometry of binding is layers. Cefazolin (1 g, i.v.) was administered before and approximately four FKBPs per RyR complex, i.e. one after surgery. FKBP to one RyR monomer [13] . However, in contrast to After allowing 1 week for recovery, the pacemaker was the general concensus as to effects of FKBP12 on RyR-1, programmed to pace at 250 bpm. Dogs were monitored there is controversy as to the modulatory influence exerted daily for clinical signs of heart failure. Approximately 1 h by FKBP12.6 over RyR-2. Kaftan et al. [15] found that after the termination of the rapid RV pacing, LV pressure rapamycin, a drug that inhibits the prolyl isomerase was measured using a 7-F micromanometer (Millar, Texas, activity of FKBP12.6 and dissociates this protein from USA) inserted percutaneously via the carotid artery, and RyR-2, increases the open probability and reduces the two-dimensional short-axis echocardiograms were obtained 21 current amplitude of cardiac Ca -release channels. On the at the level of the head of the papillary muscle. other hand, Timerman et al. [14] showed that removal of
The care of the animals and the protocols used were in FKBP12.6 from the canine RyR-2 (by means of FK590, an accord with guidelines laid down by the Animal Ethics FK506 analogue) did not alter the sensitivity of the channel Committee of Yamaguchi University School of Medicine. 21 to Ca -induced activation.
Very recently we proposed a novel mechanism of cardiac dysfunction on the basis of our finding that in a 2.2. Preparation of SR vesicles 21 canine model of heart failure a prominent abnormal Ca leak occurs through RyR, presumably following a partial SR vesicles were prepared as described previously loss of RyR-bound FKBP12.6 and the resultant conforma- [9, 17] , according to the method of Kranias et al. [18] . Left 21 tional change in RyR [16] . This abnormal Ca leak might ventricles were homogenized in a solution containing 30 21 mM Tris-malate, 0.3 M sucrose, 5 mg / l leupeptin and 0.1 possibly cause Ca overload and consequent diastolic mM PMSF, at pH 7.0 (Solution I). The homogenate was dysfunction, as well as systolic dysfunction.
centrifuged at 5500 g for 10 min and the resultant In the present study, we set out to assess whether 21 supernatant was filtered through four layers of cheesecloth FKBP12.6 is involved in the abnormality of the Cabefore centrifugation at 12 000 g for 20 min. The supernarelease function seen in heart failure. To this end, we tant was again filtered through cheesecloth and centrifuged investigated whether an alteration of interaction between at 143 000 g for 30 min. The pellet was resuspended in a FKBP12.6 and RyR-2 might be involved in the pathosolution containing 0.6 M KCl, 30 mM Tris-malate, 0.3 M genesis of the abnormal channel-gating function of RyR-2 sucrose, 5 mg / l leupeptin and 0.1 mM PMSF, at pH 7.0 we earlier observed in the failing heart.
(Solution II). This suspension was centrifuged at 143 000 g for 45 min. The pellet was resuspended again in Solution II, homogenized and centrifuged at 143 000 g as described 2. Methods above. The pellet was suspended in Solution I and centrifuged at 143 000 g. The Ca -release assay was performed as described previously [9, 17] . SR vesicles (0.5 mg / ml) were incubated in a solution containing 0.15 M KC1, 10 mM NaN , 2.5 3 mM MgATP and 20 mM MES, pH 6.8 (adjusted using 21 21 KOR) (Solution A) for 5 min to load the SR with Ca . final amount of Ca released at an infinite time, and k is Then, 1 volume of Solution A was mixed with 1 volume of the rate constant of release. Solution B (containing 0.15 M KC1 and 20 mM MES; adjusted to pH 6.8 using KOH). Polylysine (0.74 mM; M r 3 27 000) was added to Solution B when needed. The final 2.5.
[ H]dihydro-FK506 assay concentration of polylysine after mixing was 0.37 mM, at 21 3 which a half-maximal stimulation of Ca release was [ H]Dihydro-FK506 binding was performed in CHAPS- 21 obtained [9] . The Ca concentration in each of the two solubilized SR by the LH-20-column method with slight solutions was buffered at 3 mM using an EGTA-calcium modifications [13, 24, 25] . SR vesicles were first solubilized buffer (0.212 mM CaC1 , 0.25 mM EGTA, pH 6.8). In the in FK506-binding buffer (20 mM NaPO , pH 7.2, 0.5% 2 4 presence or absence of 30 mM FK506, the time course of CHAPS, 2 mM DTT, 5 mg / ml BSA and 0.02% NaN ) at 3 21 the polylysine induced Ca release was monitored using a a protein concentration of 0.1 mg / ml. Then, samples of the stopped-flow apparatus (Unisoku RSP-6015, Osaka), with solubilized vesicles were incubated for 30 min at 378C in where y is the amount of Ca released at time t, A is the plots. 21 2.6. Ca -ATPase activity assay 21 Ca -ATPase activity in SR vesicles was evaluated by measuring the amount of Pi released during the reaction initiated by adding ATP [9, [26] [27] [28] . The assay mixture in a total assay volume of 500 ml contained 0.15 M KCl, 20 mM MES, pH 6.8 (adjusted using KOH), 0.3 mM MgCl , 2 10 mM NaN , 6 mM ionophore A-23187, 0.212 mM 3 21 CaC1 , 0.25 mM EGTA (free [Ca ]53 mM) and SR 2 vesicles (0.1 mg). To start the reaction, 1.0 mM ATP was added to the above priming solution in the presence or absence of various concentrations of FK506. The amount of Pi released was calculated by converting nm (absorbance of 0.1% malachite green) to nmol by means of a standard linear line.
Statistics
An unpaired t-test was used to compare binding data and kinetic parameters between normal and heart failure groups. A one-way analysis of variance was employed to compare the effect of FK506 on the polylysine-induced 3 enhancement of [ H]ryanodine binding these groups. When a significant trend was identified by the F test, Scheffe's post-hoc test was used to compare the data. A P value less than 0.05 was accepted as statistically significant. 
in an open state, the increase in gin. In confirmation of our previous report [9] , the rate of 21 21 ryanodine binding seen upon the addition of a CaCa release was found to be slower in failing SR vesicles release trigger (such as polylysine) indicates activation of than in normal SR vesicles. In both types of SR vesicles, In the absence of polylysine, the Ca release from are summarized in Table 2 with Solution B; data not shown). Hence the induced Ca they were both unchanged in the failing SR vesicles. In 21 release was solely dependent on polylysine. Fig. 3a shows normal SR vesicles, the amount of Ca release expressed activity. In line with our previous finding [9] , the CaATPase activity was significantly lower in failing SR vesicles than in normal SR vesicles (P,0.05). None of the each performed on a different preparation. 21 nicely shown a close relationship between the Ca mechanism underlying the altered RyR function in heart transient and the subsequent tension development. Furtherfailure. This greater insight is based on the following more, in an other study, on rat papillary muscle [31] found a significant reduction in the peak of the Ca respect to RyR, as we reported previously [16] . transient in heart failure. However, in both studies the Taking the present findings together with these previous 21 duration of the Ca transient was significantly prolonged. reports [16, 35] , strongly suggests to us that when a 21 The delayed fall in the descending portion of the Ca sufficiently high concentration of FK506 (or rapamycin) is transient might be caused by a decrease in the expression applied to cardiac myocytes, cooperation among the four 21 and / or activity of the SR Ca -ATPase (SERCA II) [34] . RyR subunits is disrupted, thus destabilizing the channel 21 The decreased rate of acceleration in the Ca transient and in turn inducing an abnormality in the channel-gating (prolongation of time to peak) may be mainly secondary to function of RyR. suggests that the gating function of the SR Ca release cardiac muscle [13, 14] , while FKBP12 exists in a channel is altered in heart failure, leading to a decrease in soluble form in the cytoplasm [36] . In addition, in our 21 3 the acceleration of both the [11, 12, 29] . Rather, the inhibition
• Seventh, although the present model of tachycardia- 21 by FK506 of ryanodine binding and Ca release may induced heart failure involves a well-defined, predictresult from a conformational change in RyR that able and progressive LV dilatation as well as a contracfollows a dissociation of FKBP12.6 from RyR. Since tile dysfunction and neurohumoral activation [39] , it the FK50.6-induced decrease in ryanodine binding differs from chronic models of heart failure in two 21 appeared to be smaller than that in the rate of Ca ways: it lacks a hypertrophic compensatory phase [40] release, the FK50.6-induced conformational change in and the heart failure disappears if pacing is discon- 21 RyR may modulate ryanodine binding and Ca release tinued after 3 weeks [41] . Clearly more work using in different ways.
other models of heart failure are needed to clarify • Fourth, we need to address the question as to whether whether there really is an abnormality in the kinetics of 21 or not Ca release is influenced by a possible direct RyR in chronic heart failure. 21 effect of FK506 on Ca reuptake, which may occur 21 simultaneously during Ca release. As mentioned In conclusion, in heart failure an altered interaction 21 above, there was no direct effect of FK506 on Cabetween FKBP12.6 and the ryanodine receptor may induce ATPase activity in either normal or failing SR vesicles.
an instability of RyR-channel properties and a resulting 21 21 Furthermore, to eliminate Ca uptake, polylysine-inimpairment of the Ca -release function of RyR. 21 duced Ca release was evaluated in the presence of 1 21 mM thapsigargin (SR Ca -ATPase inhibitor). However, both in normal and failing SR vesicles, the time Acknowledgements 
